HL-300 Ointment in Healthy Volunteers

NCT07684937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: HL-300
DRUG: HL-300
DRUG: HL-300
DRUG: HL-300

Sponsor

Hangzhou Highlightll Pharmaceutical Co., Ltd